Mechanisms of Ligand-Induced Desensitization of the 5-Hydroxytryptamine2A Receptor
Open Access
- 1 February 2002
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 300 (2) , 468-477
- https://doi.org/10.1124/jpet.300.2.468
Abstract
We have examined the cellular processes underlying the desensitization of the 5-hydroxytryptamine (5-HT)2A receptor induced by agonist or antagonist exposure. Treatment of C6 glioma cells with either 5-HT or the 5-HT2A receptor antagonist ketanserin resulted in an attenuation in 5-HT2A receptor function, specifically the accumulation of inositol phosphates stimulated by the partial agonist quipazine. 5-HT-induced desensitization of the 5-HT2A receptor involved receptor internalization through a clathrin- and dynamin-dependent process because it was prevented by concanavalin A, monodansylcadaverine, and by expression of the dominant negative mutants β-arrestin (319–418) and dynamin K44A. Although short-term (i.e., 10 min) 5-HT and ketanserin exposure resulted in the same degree of desensitization, ketanserin-induced desensitization was not prevented by these agents and did not involve receptor internalization. In contrast, prolonged ketanserin exposure (i.e., 2 h) resulted in 5-HT2A receptor internalization through a clathrin- and dynamin-dependent process, as was observed after agonist treatment. Inhibitors of protein kinase C or calcium-calmodulin kinase II did not attenuate or prevent 5-HT-induced desensitization of the receptor. 5-HT2A receptor desensitization induced by 5-HT and prolonged ketanserin treatment, but not by short-term ketanserin treatment, was prevented by the expression of the dominant negative mutant of G protein-coupled receptor kinase (GRK)2, GRK2-K220R, and by an anti-GRK2/3 antibody. Our data indicate a dual mechanism of early and late desensitization by the antagonist ketanserin. Short-term ketanserin treatment reduced the specific binding of the agonist radioligand [125I](±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane ([125I]DOI) and the ability of 5′-guanylylimidodiphosphate to attenuate this binding, suggesting that at the early stage of antagonist-induced desensitization the capacity of the 5-HT2A receptor to couple to G protein is impaired.Keywords
This publication has 33 references indexed in Scilit:
- The role of protein kinase C in the regulation of serotonin-2A receptor expressionJournal of Neurochemistry, 2001
- The Dynamin-dependent, Arrestin-independent Internalization of 5-Hydroxytryptamine 2A (5-HT2A) Serotonin Receptors Reveals Differential Sorting of Arrestins and 5-HT2A Receptors during EndocytosisJournal of Biological Chemistry, 2001
- Regulation of 5-HT2A receptor mRNA levels and binding sites in rat frontal cortex by the agonist DOI and the antagonist mianserinNeuropharmacology, 2000
- Multiple endocytic pathways of G protein-coupled receptors delineated by GIT1 sensitivityProceedings of the National Academy of Sciences, 2000
- Partial agonists and G protein-coupled receptor desensitizationPublished by Elsevier ,1999
- G‐protein coupled receptor kinases as modulators of G‐protein signallingThe Journal of Physiology, 1999
- Induction of mutant dynamin specifically blocks endocytic coated vesicle formation.The Journal of cell biology, 1994
- Glial cell-specific expression of the serotonin 2 receptor gene: selective reactivation of a repressed promoterMolecular Brain Research, 1993
- Serotonin2 agonist administration down-regulates rat brain serotonin2 receptorsLife Sciences, 1988
- Effects of Substance P on Nicotinic Acetylcholine Receptor Function in PC 12 CellsJournal of Neurochemistry, 1987